535 results about "Hydroxyquinolines" patented technology

Bis(hydroxyquinoline)-metal complexes and the use thereof as bleach catalysts are described.

The present invention relates to a class of small molecule hydroxamic acid compounds capable of inhibiting histone deacetylases (HDACs). The present invention also relates to methods of preparation of hydroxamic acid HDAC inhibitor compounds of the invention, which are N-substituted-1,2,3,4-tetrahydroisoquinoline hydroxamic acid derivatives, and their incorporation into pharmaceutical compositions and methods of administration. The present invention also relates to N-substituted-1,2,3,4-tetrahydroisoquinoline hydroxamic acid derivatives, which may be prepared as a hydroxamic acid HDAC inhibitor compound library that can be utilized in screening methods known in the art.

The 8-hydroxy quinoline type chelated resin has 8-hydroxy quinoline fixed onto macroporous silica gel through silanizing reagent and paraformaldehyde as spacer arm and bonding amount of 120-542 umol/g. Its synthesis process includes the steps of: pre-treating macroporous silica gel; introducing spacer arm; fixing ligand and acid washing to set via drying intermediate product II, washing with alcohol and drying for several times, washing with hydrochloric acid, and washing with deionized water to neutral so as to obtain yellow chelated resin. The resin has simple synthesis process, mild reaction condition, short synthesis time, easy control, high synthesis efficiency, low cost, high rigidity and high metal ion complexing capacity, and may be used in on-line enriching analysis of trace metal, enriching recovery of noble metals, purifying industrial waste water, etc.

The invention belongs to the field of chemical drugs, and discloses a ruthenium complex capable of inhibiting tumor angiogenesis and a preparation method and application thereof. The ruthenium complex provided by the invention has a structure shown in a formula I or II. The preparation method comprises the following steps of: dropwise adding a silver nitrate solution to a sodium salt solution, stirring and reacting, then filtering, washing and vacuum drying a precipitate, and thereby obtaining a ligand O-O; taking ruthenium chloride, L, and lithium chloride to be dissolved in N-, N-dimethyl formamide, heating and refluxing under the protection of argon atmosphere to obtain an intermeidate Ru (L2) Cl22 +; allowing the ligand O-O and the Ru (L2) Cl22 + to be dissolved in an ethanol/water mixed solvent, heating and refluxing to obtain the ruthenium complex shown in the formula I; and allowing the Ru (L2) Cl22 +, 8- hydroxyquinoline, and ammonium acetate to be dissolved in ethanol, and heating and refluxing under the protection of argon atmosphere to obtain the ruthenium complex shown in the formula II. The ruthenium complex has the advantages of good stability, uneasiness in hydrolysis, good solubility, low toxicity, and the ability to inhibit tumor angiogenesis, and is easily absorbed by the human body.

The invention relates to a flower antistaling agent with added plant growth regulator, wherein 1L of the water contains the following constituents: sucrose 5-20g, 8- hydroxyquinoline 0.1-0.5g, gibberellin 0.02-0.08g, cytokinin 0.01-0.09g, plant growth retardant 0.20-0.8g, arginine 0.015-0.045g, organic acid 0.1-0.5g and inorganic salt 0.005-1.5g.

The structure and preparation of antibiotics incorporating borinic acid complexes are disclosed, especially hydroxyquinoline, imidazole and picolinic acid derivatives, along with compositions of these antibiotics and methods of using the antibiotics and compositions as bactericidal and fungicidal agents as well as therapeutic agents for the treatment of diseases caused by bacteria and fungi.

The invention discloses two halogenated 8-hydroxyquinoline platinum (II) complexes and a synthesis method and application thereof. The structures of the halogenated 8-hydroxyquinoline platinum (II) complexes are shown in the formula (I), and the synthesis method comprises the steps that an 8-hydroxyquinoline derivative and dichloro bis(dimethyl sulfoxide) platinum are taken and subjected to a coordination reaction in a polar solvent, and the halogenated 8-hydroxyquinoline platinum (II) complexes are obtained. It is shown through experiments carried out by an applicant that the halogenated 8-hydroxyquinoline platinum (II) complexes have good activity of inhibiting the proliferation of certain tumor cell strains and can selectively inhibit the growth of bladder cancer T-24 cells, and the apoptosis of the tumor cells is induced under the function of targetedly interfering with mitochondria; meanwhile, the toxicity of the complexes to human normal cells HL-7702 is low. The structures of the halogenated 8-hydroxyquinoline platinum (II) complexes and the structure of the 8-hydroxyquinoline derivative are shown in the following formulas (I) and (II) respectively, wherein the formulas (I)and (II) are shown in the description, and R1 represents Cl or Br.

The invention belongs to the field of chelate resin materials, and particularly relates to a novel immobilized 8-hydroxyquinoline type chelate adsorption material and a preparation method thereof. 0.95-1.85mmol/g of ligand 8-hydroxyquinoline is bonded to the surface of a silica gel micro-particle modified by hydroxyethyl methacrylate (HEMA). The preparation method includes the steps: grafting the hydroxyethyl methacrylate on the surface of the silica gel micro-particle modified by amino containing silane coupling agents; and fixing the ligand 8-hydroxyquinoline on the surface of the silica gel micro-particle modified by polymer. The material is large in 8-hydroxyquinoline bonding quantity, simple in synthesis process, moderate in condition, short in time, easy to control and fine in mechanical property, is repeatedly used, has a high coordinated complexing capacity for metal ions, can enrich and recycle various precious metal ions, particularly has excellent adsorption and selection performances for heavy metals such as copper, nickel and lead, and can be used for purifying industrial wastewater.

The invention discloses a sulfuric acid-boric acid-additive ternary anodizing fluid, which is prepared by adding 1.6-7.6ml of sulfuric acid, 0.1-1.1g of boric acid and 5-100mg of additive into 100ml of deionized water. The additive is benzotriazole, 2-mercaptobenzothiazole, dithizone or 8-oxyquinoline. The anodizing fluid of the invention is the improvement of aluminium and aluminium alloy sulfuric acid-boric acid binary anodizing fluid, and cupreous efficient cathodic corrosion inhibitor is added to enable that preferential adsorption of the corrosion inhibitor is carried out on the copper-containing particle position of an aviation aluminum alloy surface, thus forming a compact reticulatepattern complexing product, providing targeted protection on copper-containing aluminum alloy phase particles, decreasing the current concentration tendency, and inhibiting excessive growth of oxidation film cavern defect at the position of the copper-containing aluminum alloy phase particles.

The invention discloses an organic monomer containing 8-hydroxyquinoline boron, a conjugated polymer based on the monomer, a preparation method and application, and belongs to the technical field of preparation of the conjugated polymer containing a main group element and application of photoelectrical properties of the conjugated polymer. The preparation method of the compound has the outstanding advantages of being easy and convenient to operate, mild in reaction condition, capable of conducting large-scale production, high in adaptability to substrate, free of column chromatography purification and the like; the prepared monomer and the polymer are good in photochemical stability, high in fluorescence quantum yield and excellent in solubility, and a firm foundation is laid for sensing application and photoelectric property application of the monomer and the polymer.

The present invention provide 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula (I). These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.